{"cmr":"ca-cm-kg/CSE/PHRM","since":null,"total":8,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ca-cm-kg/CSE/PHRM","date":"2026-10-30","event_type":"newswire_release","title":"PharmaTher Builds Portfolio of Personalized, 3D-Printed Peptide Products for New U.S. Peptide Pathway, Led by Colon-Targeted KPV and BPC-157","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/321580/PharmaTher-Builds-Portfolio-of-Personalized-3DPrinted-Peptide-Products-for-New-U.S.-Peptide-Pathway-Led-by-ColonTargeted-KPV-and-BPC157","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rxYbDB46camRz2uFowe0toge2CudcgGv3T4_47UObFm27Cuq5pzLP99Yja5SMkE8rZrTeLBZNfgF4ZSmbzOdCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/PHRM","date":"2026-10-29","event_type":"newswire_release","title":"PharmaTher Builds Portfolio of Personalized, 3D-Printed Peptide Products for New U.S. Peptide Pathway, Led by Colon-Targeted KPV and BPC-157","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/321580/PharmaTher-Builds-Portfolio-of-Personalized-3DPrinted-Peptide-Products-for-New-U.S.-Peptide-Pathway-Led-by-ColonTargeted-KPV-and-BPC157","read_by":"Tavily search (wire domains) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"L-zeDOu4KDXOLe-mEnAvyea0_iSsnPshDtD1P6ngDq4KwLc3xrEkwfQkK-iW79zWGNHEK7N2qS7_e2MOhvFrDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/PHRM","date":"2026-10-28","event_type":"newswire_release","title":"PharmaTher Submits Orphan Drug and Rare Pediatric Disease Designation Applications to FDA for 3D-Printed Creatine Monohydrate in GAMT Deficiency","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/321351/PharmaTher-Submits-Orphan-Drug-and-Rare-Pediatric-Disease-Designation-Applications-to-FDA-for-3DPrinted-Creatine-Monohydrate-in-GAMT-Deficiency","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"uL4ShfpMMRa2rsTTAp1Nk_KBkfcwh4pywGlByCGZkPDzY98Yo5FtGcSGHTFa6yc_2GxxBAiPNf-esR6jECFWBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/PHRM","date":"2026-10-07","event_type":"newswire_release","title":"PharmaTher Launches M3DICINES(TM) National Network Program to Provide 3D-Printed Medicines for Rare Diseases, Discontinued Medicines, Drug Shortages and National Emergencies","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/317817/PharmaTher-Launches-M3DICINESTM-National-Network-Program-to-Provide-3DPrinted-Medicines-for-Rare-Diseases-Discontinued-Medicines-Drug-Shortages-and-National-Emergencies","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"46VRG1fAB5OVhYKkmAf-BHiVFd0NHb22kpBrfEQ1Z7rppxrNbkXik0r_XPkg4zGWFITnHtppbWY4ye0fiem8CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/PHRM","date":"2026-10-05","event_type":"newswire_release","title":"PharmaTher Outlines Corporate Strategy and Upcoming Milestones; Launches New Corporate Website and Rebrands PERSONALIZ3D as M3DICINES","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/317325/PharmaTher-Outlines-Corporate-Strategy-and-Upcoming-Milestones-Launches-New-Corporate-Website-and-Rebrands-PERSONALIZ3D-as-M3DICINES","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"a7sAayLs7546hR9nCZO5xVn-ize9lqEnJaWvIbMWswoucTRubHJxyjdlP9M_Jx1g8i85LjBdpgR21X-a-OBQAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/PHRM","date":"2026-10-01","event_type":"corporate_action","title":"PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/316740/PharmaTher-Enters-into-Exclusive-North-American-Distribution-Agreement-with-Craft-Health-for-CraftMakeTM-Pharmaceutical-3D-Printing-Platform","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4ZUv7CL5OvfIw-PRRozuhQ_1OCJrGnA7Z8pfDR44GoID0qROzISwRCp0m5IplLWs7hvih5WxBLM4fDTFPQ8QBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/PHRM","date":"2025-10-02","event_type":"newswire_release","title":"PharmaTher Provides Corporate Update on Ketamine","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/10/02/3160310/0/en/pharmather-provides-corporate-update-on-ketamine-development-and-commercial-strategy.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"e8i6qhYD2_up_3ST7pTSm4icnlLRDff758ofwmk6SNM80Y4vFbLo2uD_w0YTAflml0JrQyqBjNqOfjntx3KPAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/CSE/PHRM","date":"2025-10-01","event_type":"newswire_release","title":"PharmaTher Announces Sale of Ketamine ANDA with Potential","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/10/01/3159435/0/en/pharmather-announces-sale-of-ketamine-anda-with-potential-to-generate-over-us-25-million-in-milestone-and-profit-sharing-payments.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0WcIn1TauoLj-95k422W3UoWHoC4G_e4aNzZNSdbGWFkKXvWIM1k-VBWZywekPX8DikRj2bQXTDEh4CjD-PXBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}